Bio-Rad Laboratories Inc. logo

Bio-Rad Laboratories Inc.

BIO | NYSE
Chart Builder DCF Calculator
$378.33
+$1.92 (+0.51%)
Sep 21, 2026, 11:10 AM ET · Market open

Company Profile

Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.

Key Executives

Name Position
Norman D. Schwartz Chairman & Chief Executive Officer
Jonathan DiVincenzo President & Chief Operating Officer
Roop K. Lakkaraju Executive Vice President & Chief Financial Officer
Courtney C. Enloe Executive Vice President, General Counsel & Secretary
James J. Barry Executive Vice President & President of Life Science Group
Matthew Werner Senior Vice President and Chief Compliance & Privacy Officer
Michael Crowley Executive Vice President of Global Commercial Operations
Nanditha R. Yelamanchi Executive Vice President of Global Human Resources
Rajat Mehta Executive Vice President of Global Commercial Operations
Ruben Argueta Vice President of Investor Relations

Latest SEC Filings

Date Type Title
Sep 03, 2026 4 Filing
Sep 03, 2026 4 Filing
Sep 03, 2026 4 Filing
Aug 04, 2026 10-Q Quarterly Report
Aug 04, 2026 8-K Current Report
Jul 28, 2026 4 Filing
May 13, 2026 SD Filing
May 13, 2026 4 Filing
Apr 30, 2026 S-8 Filing
Apr 30, 2026 10-Q Quarterly Report
View All SEC Filings
Bio-Rad Laboratories Inc.
Bio-Rad Laboratories Inc. logo
Country United States
IPO Date Feb 26, 1980
Industry Medical - Devices
Sector Healthcare
Employees 7,450
CEO Norman D. Schwartz

Contact Details

1000 Alfred Nobel Drive Hercules, California 94547 United States

Stock Details

Ticker Symbol BIO
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000012208
CUSIP Number 090572207
ISIN Number US0905722072
SIC Code 3826

© 2026 bestshares.com. All rights reserved.